U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB


[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

                For the quarterly period ended September 30, 2004

[ ]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

                         For the transition period from

                          Commission File No. 000-31361

                            FUTOMIC INDUSTRIES, INC.
        (Exact name of small business issuer as specified in its charter)

        New Jersey                                              22-3720628
(State or other jurisdiction of                             (I.R.S. Employer
incorporation or organization)                              Identification No.)

                                 7627-83 AVENUE
                       EDMONTON, ALBERTA, CANADA T6C 1A2
                    (Address of Principal Executive Offices)

                                 (780) 722-1104
                           (Issuer's telephone number)


     (Former name, address and fiscal year, if changed since last report)


Check whether the issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for
such shorter period that the issuer was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
Yes [ X] No [ ]

State the number of shares outstanding of each of the issuer's classes of common
equity, as of November 22, 2004: 16,946,000 shares of common stock outstanding,
$0.0001 par value.

Part I-- FINANCIAL INFORMATION

  Item 1. Financial Statements

  Item 2. Management's Discussion and Analysis of Financial Condition

  Item 3. Control and Procedures

Part II-- OTHER INFORMATION

  Item 1. Legal Proceedings

  Item 2. Changes in Securities

  Item 3. Defaults Upon Senior Securities

  Item 4. Submission of Matters to a Vote of Security Holders

  Item 5. Other Information

  Item 6. Exhibits and Reports on Form 8-K

Signature


Item 1. Financial Information
-----------------------------

BASIS OF PRESENTATION

The accompanying reviewed financial statements are presented in accordance with
generally accepted accounting principles for interim financial information and
the instructions to Form 10-QSB and item 310 under subpart A of Regulation S-B.
Accordingly, they do not include all of the information and footnotes required
by generally accepted accounting principles for complete financial statements.
In the opinion of management, all adjustments (consisting only of normal
occurring accruals) considered necessary in order to make the financial
statements not misleading, have been included. Operating results for the nine
months ended September 30, 2004 are not necessarily indicative of results that
may be expected for the year ending December 31, 2004. The financial statements
are presented on the accrual basis.


<PAGE>
                             FUTOMIC INDUSTRIES INC.
                                 And Subsidiary
                          (a development stage company)

                              FINANCIAL STATEMENTS







                            AS OF SEPTEMBER 30, 2004





<PAGE>


                             FUTOMIC INDUSTRIES INC.
                                 And Subsidiary
                          (a development stage company)

                     Financial Statements Table of Contents




     FINANCIAL STATEMENTS                                     Page #






     Balance Sheet                                              1


     Statement of Operations and Retained Deficit               2


     Statement of Stockholders Equity                           3


     Cash Flow Statement                                        4


     Notes to the Financial Statements                          5-7


<PAGE>

<TABLE>

                             FUTOMIC INDUSTRIES INC.
                                 And Subsidiary
                          (a development stage company)
                                 BALANCE SHEETS
                 As of September 30, 2004 and December 31, 2003



                                     ASSETS

<CAPTION>

CURRENT ASSETS                                              September 30, 2004       December 31, 2003
<S>                                                              <C>                      <C>
        Cash                                                     $ 197,319                $     741
        Receivable - Selectrics of Canada                                0                    6,961
        Employee advances                                              147                    1,837
                                                                 ---------                ---------


                      TOTAL CURRENT ASSETS                         197,465                    9,539
                                                                 ---------                ---------



FIXED ASSETS

        Research Equipment                                           2,925                      488
        Furniture                                                      735                        0
        Office equipment                                             1,928                        0
        Computers and software                                       2,401                        0
        Accumulated Depreciation                                      (774)                    (293)
                                                                 ---------                ---------

              TOTAL PROPERTY AND EQUIPMENT                           7,215                      195
                                                                 ---------                ---------

 TOTAL ASSETS                                                    $ 204,680                $   9,734
                                                                 =========                =========

                      LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES

 Accounts payable                                                $  19,726                $  15,000
 Wages payable                                                      27,711                        0
 Shareholder loan                                                   37,924                   26,751
                                                                 ---------                ---------

                      TOTAL LIABILITIES                             85,361                   41,751
                                                                 ---------                ---------

STOCKHOLDERS' EQUITY

  Preferred Stock - Par value $0.0001;
    20,000,000 shares authorized;
    none issued and outstanding                                                                   0

  Common Stock - par value $0.0001;
    100,000,000 shares authorized;
    Shares issued and outstanding:
      16,946,000 and 16,371,000, respectively                        1,695                    1,637

  Additional paid in capital                                       383,937                  118,995

  Foreign currency translation adjustment                            1,005                      871

  Accumulated Deficit                                             (267,318)                (153,520)
                                                                 ---------                ---------

  Total stockholders' equity                                       119,319                  (32,017)
                                                                 ---------                ---------


      TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                 $ 204,680                $   9,734
                                                                 =========                =========

</TABLE>

   The accompanying notes are an integral part of these financial statements.


                                       1

<PAGE>

<TABLE>

                             FUTOMIC INDUSTRIES INC.
                                 And Subsidiary
                          (a development stage company)
                            STATEMENTS OF OPERATIONS
                  For the nine months ended September 30, 2004,
       from inception (June 24, 2003) through September 30, 2003, and from
              inception (June 24, 2003) through September 30, 2004

<CAPTION>

                                                          Nine Months               From Inception             From Inception
                                                             Ended                     Through                     Through
                                                        Sept. 30,   2004             Sept. 30, 2003             Sept. 30, 2004
                                                          ------------                ------------                ------------
<S>                                                       <C>                         <C>                         <C>
     SALES                                                $          0                $          0                $          0
     COST OF SALES                                                   0                           0                           0
                                                          ------------                ------------                ------------

     GROSS PROFIT                                                    0                           0                           0


     GENERAL AND ADMINISTRATIVE EXPENSES                        55,020                      35,143                      99,957
     RESEARCH AND DEVELOPMENT COSTS                             58,798                     103,332                     167,059
                                                          ------------                ------------                ------------

     OPERATING INCOME (LOSS)                                  (113,818)                   (103,475)                   (267,016)

     INTEREST INCOME                                                20                           0                          20

     INTEREST (EXPENSE)                                              0                           0                        (322)
                                                          ------------                ------------                ------------

     NET INCOME (LOSS)                                        (113,798)                   (138,475)                   (267,014)

     ACCUMULATED DEFICIT, BEGINNING BALANCE               $   (153,520)                         (0)                         (0)
                                                          ------------                ------------                ------------

     ACCUMULATED DEFICIT, ENDING BALANCE                  $   (267,318)               $   (138,475)               $   (267,318)
                                                          ============                ============                ============

NET EARNINGS PER SHARE

         Basic
         Net loss per share                               $       (.01)               $       (.02)

      Weighted Average
      Number of Common Shares Outstanding                   16,427,250                   6,821,250


   The accompanying notes are an integral part of these financial statements.
</TABLE>

<PAGE>

<TABLE>

                             FUTOMIC INDUSTRIES INC.
                                 And Subsidiary
                          (a development stage company)
                             STATEMENT OF OPERATIONS
                  For the three months ended September 30, 2004

<CAPTION>

                                                  Three Months            Three Months
                                                 Sep. 30, 2004           Sep. 30, 2004

<S>                                               <C>                      <C>
SALES                                             $       0                $       0
COST OF SALES                                             0                        0
                                                  ---------                ---------

GROSS PROFIT                                              0                        0

GENERAL AND ADMINISTRATIVE EXPENSES                  26,276                   34,893
RESEARCH AND DEVELOPMENT COSTS                        1,998                  103,332

OPERATING INCOME (LOSS)                             (28,274)                (138,225

INTEREST INCOME                                          20                        0
INTEREST (EXPENSE)                                        0                        0
                                                  ---------                ---------

NET INCOME (LOSS)                                 $ (28,254)               $(138,475)


</TABLE>

   The accompanying notes are an integral part of these financial statements.


                                       2

<PAGE>

<TABLE>

                            FUTOMIC INDUSTRIES INC.
                                 And Subsidiary
                         (a development stage company)
                       STATEMENT OF STOCKHOLDERS' EQUITY
            From inception (June 24, 2003)through September 30, 2004

<CAPTION>

                                                                             FOREIGN
                                                               ADDITIONAL    CURRENCY
                                                    COMMON      PAID IN    TRANSLATION   ACCUMULATED
                                    SHARES          STOCK       CAPITAL     ADJUSTMENT     DEFICIT        TOTAL
                                -------------     ---------   -----------  -----------  ------------  ------------
<S>                               <C>             <C>        <C>          <C>          <C>           <C>
Equity Balances pre-merger         5,000,000      $    500   $   2,502     $       0   $   (4,502)   $   (1,500)

Shares issued in exchange
  of stock for acquisition
  of subsidiary on August
  15, 2003 for $0.01 per share
  on a one-for-one exchange
  of 11,371,000 common shares
  are as follows:

  Exchange for 5,000,000 shares
  Adjustment to accumulated
  deficit upon merger                                           (4,502)                     4,502             0

  Stock issued for the            10,000,000      $  1,000   $ 102,582     $       0   $        0    $  103,582
  purchase of research,
  technology and applied
  for patents for a
  value of $0.01 per share
  on July 7, 2003.

  Stock issued for cash            1,250,000           125      12,375                                   12,500
  on July 3, 2003 for $0.01
  per share.

  Stock issued for cash              121,000            12       6,038                                    6,050
  on July 18, 2003 for $0.05
  per share.

Foreign currency translation
  adjustment                                                                     871                        871

Net loss                                                                                 (153,520)     (153,520)
                                 -------------  ---------  -----------  ------------  ------------  -----------

Total, December 31, 2003          16,371,000         1,637     118,995           871     (153,520)      (32,017)

Foreign currency translation
  adjustment                                                                     134                        134

Stock issued for cash
on March 15, 2004 for $0.20
per share                             75,000             8      14,992                                   15,000

Stock issued for cash
on July 15, 2004 for $0.50
per share                            500,000            50     249,950                                  250,000

Net loss                                                                                 (113,798)     (113,798)
                                 -------------  ---------  -----------  ------------  ------------  -----------

Total, September 30, 2004         16,946,000      $  1,695   $ 383,937    $    1,005   $ (267,318)   $  119,319
                                 =============  =========  ===========  ============  ============   ==========

</TABLE>



   The accompanying notes are an integral part of these financial statements.

                                       3


<PAGE>

<TABLE>

                            FUTOMIC INDUSTRIES INC.
                                 And Subsidiary
                         (a development stage company)
                 For the nine months ended September 30, 2004,
         from inception (June 24, 2003) through September 30, 2003, and
           from inception (June 24, 2003) through September 30, 2004

<CAPTION>

CASH FLOWS FROM OPERATING ACTIVITIES
                                                                    Nine Months           From Inception           From Inception
                                                                      Ended                  Through                   Through
                                                                  Sept. 30, 2004          Sept. 30, 2003            Sep. 30, 2004
<S>                                                                 <C>                      <C>                      <C>
        Net income (loss)                                           $(113,798)               $(138,475)               $(267,318)
        Adjustment for stock acquisition exchange                           0                        0                    1,500
             Research costs acquired with stock                             0                        0                  103,582
        Foreign currency translation adjusment                            134                      950                    1,005
        Depreciation                                                      481                        0                      774
       (Increase) Decrease in receivable - Selectrics                   6,961                        0                        0
       (Increase) Decrease in employee advance                          1,690                        0                     (147)
             Increase (Decrease) in accounts payable                    4,726                    2,200                   19,727
        Increase (Decrease) in wages payable                           27,711                        0                   27,711
                                                                    ---------                ---------                ---------

    NET CASH PROVIDED OR (USED) IN OPERATIONS                         (72,095)                 (64,304)                (113,166)
                                                                    ---------                ---------                ---------
CASH FLOWS FROM INVESTING ACTIVITIES

        Cash paid for fixed assets                                     (7,500)                       0                   (7,989)
                                                                    ---------                ---------                ---------

                                                                       (7,500)                       0                   (7,989)
                                                                    ---------                ---------                ---------

CASH FLOWS FROM FINANCING ACTIVITIES

        Proceeds from loan from stockholder                            11,173                   25,000                   34,924
        Proceeds from issuance of common stock                        265,000                   18,550                  283,550
                                                                    ---------                ---------                ---------

                                                                      276,173                   43,550                  318,474

CASH RECONCILIATION

        Net increase (decrease) in cash                               196,578                   10,607                  197,319
        Beginning cash balance                                            741                        0                        0
                                                                    ---------                ---------                ---------

ENDING CASH BALANCE                                                 $ 197,319                $  10,607                $ 450,319
                                                                    =========                =========                =========

</TABLE>


The accompanying notes are an integral part of these financial statements.


                                       4

<PAGE>

                             FUTOMIC INDUSTRIES INC.
                                 And Subsidiary
                          (a development stage company)
                      FOOTNOTES TO THE FINANCIAL STATEMENTS

---------------------------------------------------------------------------

1.   Summary of significant accounting policies:
     ------------------------------------------

Industry - Futomic Industries Inc., (the Company), was incorporated in the state
--------
of New Jersey on April 6, 2000 and has adopted December 31 as its fiscal year
end. On August 13, 2003, the Company filed an amendment to the Certificate of
Incorporation to change the name of the Company from Segway VI Corp. to read as
3DLP International Inc. On April 19 2004, the Company filed and amendment to the
Certificate of Incorporation to change the name of the Company from 3DLP
International Inc. to read as Futomic Industries Inc. On August 15, 2003, the
Company acquired in a common stock, one-for-one, share exchange Selectrics
Corporation, (the Subsidiary), a company incorporated in the State of Delaware
on June 24, 2003 which has adopted December 31 as its fiscal year end. The
Subsidiary is an electronics hardware development company involved in the
development of visual display technologies. The Company is considered to be in
the development stage (a development stage company) since it is devoting
substantially all of its efforts to establishing new technology.

The Accounting Acquirer - Prior to this transaction, the Company was a
-----------------------
non-operating corporation with nominal assets. The owners and management of the
Selectrics Corporation, (the Subsidiary), a private operating company, have
operating control of the Company as a result of the transaction. Therefore, this
transaction is a capital transaction in substance, rather than a business
combination. That is, the transaction is equivalent to the issuance of stock by
a private company for the net monetary assets of the public corporation,
accompanied by re-capitalization. The accounting is identical to that resulting
from a reverse acquisition, except no goodwill or other intangible asset are
recorded. Because Selectrics Corporation is essentially then treated as the
acquirer for accounting purposes, the equity accounts are adjusted for the share
exchange and carried forward. Prior accumulated deficits of the Company are
adjusted to additional paid in capital therefore carrying forward the
accumulated deficit or earnings of Selectrics Corporation As such, the financial
statements for the periods prior to the merger are those of Selectrics
Corporation.

Results of Operations, Liquidity, Capital Resources and Going Concern - The
---------------------------------------------------------------------
Company's financial statements have been presented on the basis that it is a
going concern in the development stage, which contemplates the realization of
assets and the satisfaction of liabilities in the normal course of business. The
Company, a development stage company, is considered to be an ongoing entity. The
Company's shareholders may fund, at their discretion, any shortfalls in the
Company's cash flow on a day to day basis during the time period that the
Company is in the development stage. The Company may also seek both private and
public debt and/or equity funding during this time period.

Cash and Cash Equivalents - The Company considers cash on hand and amounts on
-------------------------
deposit with financial institutions which have original maturities of three
months or less to be cash and cash equivalents.

Basis of Accounting - The Company's financial statements are prepared in
-------------------
accordance with generally accepted accounting principles.


                                       5

<PAGE>

Research and Development costs - Research and Development costs are expensed as
------------------------------
incurred in accordance with generally accepted accounting principles. Costs in
association with the development of a patented technology when computer software
is developed will be capitalized when technological feasibility is established
in accordance with financial accounting standard No. 86

Income Taxes - The Company utilizes the asset and liability method to measure
------------
and record deferred income tax assets and liabilities. Deferred tax assets and
liabilities reflect the future income tax effects of temporary differences
between the financial statement carrying amounts of existing assets and
liabilities and their respective tax bases and are measured using enacted tax
rates that apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. Deferred tax assets are
reduced by a valuation allowance when in the opinion of management, it is more
likely than not that some portion or all of the deferred tax assets will not be
realized. At this time, The Company has set up an allowance for deferred taxes
as there is no company history to indicate the usage of deferred tax assets and
liabilities.

Fair Value of Financial Instruments - The Company's financial instruments may
-----------------------------------
include cash and cash equivalents, short-term investments, accounts receivable,
accounts payable and liabilities to banks and shareholders. The carrying amount
of long-term debt to banks approximates fair value based on interest rates that
are currently available to The Company for issuance of debt with similar terms
and remaining maturities. The carrying amounts of other financial instruments
approximate their fair value because of short-term maturities.

Foreign Currency Translation Adjustments - The Company applies Financial
----------------------------------------
Accounting Standard No. 52, Foreign Currency Translation. The Company applies
this standard for translation of foreign currency financial statements for the
purposes of consolidation. This standard is also applied to accounting for and
reporting foreign currency transactions.

Concentrations of Credit Risk - Financial instruments which potentially expose
-----------------------------
The Company to concentrations of credit risk consist principally of operating
demand deposit accounts. The Company's policy is to place its operating demand
deposit accounts with high credit quality financial institutions. At this time
The Company has no deposits that are at risk.

2.   Related Party Transactions:
     ---------------------------

On July 7, 2003, the Subsidiary, in a purchase agreement and a patent assignment
agreement, acquired from Mr. Ken Tetterington (a Company Officer) and Mr.
Francisco Schipperheijn two patent applications as described in draft United
States Provisional Patent Application, an internet domain and uncompleted
hardware for certain considerations and restrictions including the issuance of
10,000,000 common shares of stock in the Subsidiary. The amount paid represents
the purchase of applied for patents and the research and development materials
and labor hours associated with the applied for patents. The value of the stock
issued was expensed by the Company as research and development costs.

Partners in the Company's securities law firm, Anslow and Jaclin, LLP, were the
original incorporators of the Company and remain as shareholders in the Company.
The firm continues to perform services for the Company.

From time-to-time shareholders may advance the Company its working capital
needs. The balance at September 30, 2004 and December 31, 2003 was $37,924 and
$26,751, respectively.

The major shareholder of the Company also owns an interest in another company,
Selectrics of Canada, of which the Company has loaned $6,961 as of December 31,
2003. As of September 30, 2004 this balance was $0.

As of December 31, 2003 the Company had employee advances of $1,836. As
September 30, 2004 this balance was $147.

                                       6

<PAGE>

On March 23, 2004, the Company entered into a purchase agreement with Mr. Ken
Tetterington, a shareholder. The agreement calls for the purchase of a patent
application for the amount of $50,000 which has been expensed in the financial
statements as purchased research and development. The technology is referenced
as `A method and apparatus that causes a 2D Video game console system to
generate 3D images that can be viewed on a 2D television system in a
stereoscopic 3D.' (the "Patent")

3.   Accounts Receivable and Customer Deposits:
     ------------------------------------------

Accounts receivable and Customer deposits do not exist at this time and
therefore have no allowances accounted for or disclosures made.

4.   Use of Estimates:
     -----------------

Management uses estimates and assumptions in preparing these financial
statements in accordance with generally accepted accounting principles. Those
estimates and assumptions affect the reported amounts of assets and liabilities,
the disclosure of contingent assets and liabilities, and the reported revenue
and expenses. Management has no reason to make estimates at this time.

5.   Revenue and Cost Recognition:
     -----------------------------

The Company uses the accrual basis of accounting in accordance with generally
accepted accounting principles for financial statement reporting.

6.   Foreign Currency Translation Adjustments:
     -----------------------------------------

The Company operates a research and development facility in Canada. The Company
uses Canadian currency to operate this facility and prepares financial
statements for this facility in that currency. These statements have been
translated in accordance with Generally Accepted Accounting Principles, FAS -
52. The translation adjustments our shown as part Stockholders' Equity and do
not effect the Company's revenue and expense. The Company had $871 in
translation adjustments for the period ending December 31, 2003 and $1,005.
Transaction gains and losses are shown as revenue or expense by the Company in
the Statement of Operations. During the period ending December 31, 2003, the
Company had no transaction gains or losses.

7.   Accrued Expenses:
     -----------------

Accrued expenses consist of accrued legal, accounting and office costs during
this stage of the business.

8.   Operating and Capital Lease Agreements:
     ---------------------------------------

The Company has no agreements at this time.

9.   Stockholder's Equity:
     ---------------------

PREFERRED STOCK:

The Company has authorized 20,000,000 shares of preferred stock at a par value
of $0.0001, none of which have been issued and none are outstanding.

COMMON STOCK:

The Company has authorized 100,000,000 shares of Common Stock with a par value
of $0.0001. The Company 16,946,000 common shares issued and outstanding.


                                       7

<PAGE>

On July 23, 2004, the Company authorized the issuance of 500,000 Common Shares
in the form of a private placement offering for $250,000, or $0.50 per share.
The Company's management believes this offering to be exempt under the U.S.
Securities Act of 1933.

On March 15, 2004, the Company issued for $15,000 cash 75,000 shares of common
stock with a par value of $0.0001 and a per share value of $0.20.

On June 24, 2003, Selectrics Corporation, the Subsidiary, was incorporated in
the State of Delaware. The Subsidiary has authorized 100,000,000 common shares
of stock with no par value.

On July 7, 2003, the Subsidiary issued 10,000,000 shares of its Common Stock for
the acquisition of technology and applied patent assignments for a value of
$103,582, or $0.01 per share. The value of this transaction was expensed as
research and development costs in accordance with generally accepted accounting
principles.

On July 1, 2003, the Subsidiary authorized the issuance of 1,250,000 Common
Shares of stock to be issued from the Subsidiary's treasury in the form of a
private placement offering at a price of $0.01 per share. The Subsidiary's
management believes this offering to be exempt under the U.S. Securities Act of
1933. On July 3, 2003, the Subsidiary issued 1,250,000 Common Shares of stock to
four shareholders for a total of $12,500, or $0.01 per share.

On July 18, 2003, the Subsidiary authorized the issuance of 250,000 Common
Shares of stock to be issued from the Subsidiary's treasury in the form of a
private placement offering at a price of $0.05 per share. The Subsidiary's
management believes this offering to be exempt under the U.S. Securities Act of
1933. During August of 2003, the Subsidiary issued 121,000 Common Shares of
stock for a total of $6,050, or $0.05 per share.

On August 15, 2003, the Company authorized and approved the acquisition of
Selectrics Corporation (the Subsidiary), a wholly owned subsidiary, in an
exchange of 11,371,000 Common Shares, all of the outstanding shares of stock of
the Subsidiary on a one-for-one basis with the Company for a value of $121,882,
or $0.01 per share.

On August 15, 2003, the Subsidiary authorized and approved itself in becoming a
wholly owned subsidiary of the Company in an exchange of 11,371,000 Common
Shares, all of the outstanding shares, of stock on a one-for-one basis with the
Company for a value of $121,882, or $0.01 per share.

10.  Required Cash Flow Disclosure for Interest and Taxes Paid:
     ----------------------------------------------------------

The company has paid no amounts for federal income taxes and interest. In a
non-cash issuance of common shares, the Company issued shares of stock for the
purchase research and development costs that were expensed by the Company for a
value of $103,332.

11.  Earnings Per Share:
     -------------------

Basic earnings per share ("EPS") is computed by dividing earnings available to
common shareholders by the weighted-average number of common shares outstanding
for the period as required by the Financial Accounting Standards Board (FASB)
under Statement of Financial Accounting Standards (SFAS) No. 128, "Earnings per
Shares". Diluted EPS reflects the potential dilution of securities that could
share in the earnings.

12.  Litigation, Claims and Assessments:
     -----------------------------------

From time to time in the normal course of business the Company may be involved
in litigation. The Company's management has determined that there are no
asserted or unasserted claims that they are aware of at this time.

                                       8

<PAGE>

13.  Contracts, Agreements and Contingent Liabilities:
     -------------------------------------------------

On June 20, 2003, the Subsidiary entered into a consulting agreement with Weston
Capital Partners Ltd. whereby Weston Capital Partners Ltd. will assist, consult
and advise the Subsidiary for a term of six months on every part of the process
in getting the Subsidiary listed on the OTC.BB exchange. Consideration for these
services are a monthly fee of $1,000 per month for six months beginning June 15,
2003.

On July 7, 2003, the Subsidiary acquired technology and patent assignments from
Mr. Ken Tetterington (an Officer of the Company) and Mr. Francisco Schipperheijn
for a value of $103,332. The Subsidiary agreed to (a) Immediately pay past
patent fees and to continue to maintain in good standing, all present and future
costs, associated directly or indirectly with the patent applications and the
represented technology development. (B) Maintain professional records of the
patent applications and to inform and allow access by the vendor to all
activities related to documentation and filings of the patent applications. (C)
Not to sell the patents or the Technology in any way without the express written
consent of the inventor. The assignment agreement is not transferable or salable
by the purchaser in any way without the signed written agreement from the
vendor. (D) The Patent applications shall be vended from the vendor to the
purchaser for the sum of 10,000,000 Common Shares of the Subsidiary as
consideration upon all conditions outlined herein fully executed. And (e) If the
purchaser goes bankrupt, changes business, becomes insolvent or is unable to
carry on business the Purchaser agrees that the Patents will be forthwith
immediately be returned to the vendor, without conditions or costs.

14.  Deferred Tax Assets and Liabilities:
     ------------------------------------

The Company, currently a C-Corporation, accounts for income taxes in accordance
with Statements on Financial Accounting Standards 109. As of March 31, 2004 and
December 31, 2003, The Company had a deferred tax asset in the amount of
approximately $42,500 and 30,700, respectively, that is derived from a net
operating tax loss carryforward of $58,778 and $153,198, respectively. The
deferred tax assets will expire during the years 2024 and 2023, respectively, if
not used to offset taxable income. There is uncertainty about whether the
Company will be in a position of using these tax assets therefore an allowance
has been set up to offset these assets.

15.  Subsequent Event:
     -----------------

Subsequent to the balance sheet date, the Company issued for $250,000 cash
500,000 shares of common stock with a par value of $0.0001 and a per share value
of $0.50.



                                       9


<PAGE>

Item 2. Management's Discussion and Analysis of Financial Conditions and Results
        of Operations
--------------------------------------------------------------------------------

Plan of Operation
-----------------

As part of the purchased assets of it's wholly owned subsidiary, the
consolidated entity has two patent applications and an unfinished prototype of
its three dimensional display technology. It is now the intentions of the
Registrant to generate business by completing the prototype to a marketable
stage and pursuing an ongoing business as a manufacturer and distributor of 3
dimensional laser projector systems (`3DLp').

There is no assurance the Registrant will be successful in the completion of
it's prototype nor is there any assurance the Registrant will be successful in
the generation of an ongoing business if it completes its prototype to a
marketable product stage.

Results of Operation
--------------------

The Registrant did not have any operating income from inception (June, 2003)
through June 30, 2004. For the quarter ended June 30, 2004, the registrant
recognized an accumulated deficit of $26,866. For the seven days ended June 30,
2003, the registrant had no activity to account for in its financial statements.
For the six months ended June 30, 2004, the registrant recognized an accumulated
deficit of $85,644. $50,000 of this accumulated deficit was a result of the
consolidated entities purchase of the technology from a shareholder. General and
administrative expenses during the quarter were accrued with expenses for the
quarter comprised of costs mainly associated with legal, accounting and office
supplies.

Liquidity and Capital Resources
-------------------------------

At June 30, 2004 the Company had a cash balance of $1,580 and has relied upon
the issuance of common stock and additional capital contributions from
shareholders to fund administrative expenses. The Company wishes to generate
operating cash flows to fund future operations and also consider public and/or
private capital raises in the form of debt and/or equity securities.

Item 3. Controls and Procedures
-------------------------------

(a)  Evaluation of disclosure controls and procedures.

Our Chief Executive Officer and Chief Financial Officer (collectively the
"Certifying Officers") maintain a system of disclosure controls and procedures
that is designed to provide reasonable assurance that information, which is
required to be disclosed, is accumulated and communicated to management timely.
Under the supervision and with the participation of management, the Certifying
Officers evaluated the effectiveness of the design and operation of our
disclosure controls and procedures (as defined in Rule [13a-14(c)/15d-14(c)]
under the Exchange Act) within 90 days prior to the filing date of this report.
Based upon that evaluation, the Certifying Officers concluded that our
disclosure controls and procedures are effective in timely alerting them to
material information relative to our company required to be disclosed in our
periodic filings with the SEC.

(b)  Changes in internal controls.

Our Certifying Officer has indicated that there were no significant changes in
our internal controls or other factors that could significantly affect such
controls subsequent to the date of his evaluation, and there were no such
control actions with regard to significant deficiencies and material weaknesses.


                          PART II - OTHER INFORMATION


Item 1. Legal Proceedings

None

Item 2. Changes in Securities.

None

Item 3. Defaults Upon Senior Securities.

None

Item 4. Submission of Matters to a Vote of Security Holders.

None

Item 5. Other Information.

None

Item 6. Exhibits and Reports of Form 8-K.

     (a)  Exhibits

          31.1 Certification of CEO
          31.2 Certification of CFO


     (b)  Reports of Form 8-K

          None

<PAGE>

                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                        FUTOMIC INDUSTRIES INC.

Date:   November 22, 2004               /s/  Ken Tetterington
                                        --------------------------------
                                        Ken Tetterington
                                        President, Secretary and Director